Tobias Gerhard Named President of International Society of Pharmacoepidemiology

IFH Interim Director, Tobias Gerhard, was installed as ISPE President at ISPE’s annual conference in August.

New RCMAR Leadership

The Rutgers Asian Resource Center for Minority Aging Research (RCMAR) appoints new leadership.

Zeeshan Ahmed
No One-Size-Fits-All Artificial Intelligence Approach Works for Prevention, Diagnosis or Treatment Using Precision Medicine

Dr. Zeeshan Ahmed leads one of the first studies examining artificial intelligence and precision medicine.

Chintan Dave
Rutgers Will Conduct the Most Comprehensive Study Ever Done of High-Risk Children Newly Diagnosed with Type 1 Diabetes

Dr. Chintan Dave will lead researchers in conducting the largest study of children at risk of developing a life-threatening complication of Type 1 diabetes.

Media advisory: Ann Nguyen publishes new research in Health Affairs

Dr. Ann Nguyen of Rutgers Center for State Health Policy publishes new research in Health Affairs on NJ’s temporary licensure program.

IFH Newsletter Q2 2022

Read the latest news from the Institute for Health!

IFH Researchers Present at NJ ACTS Symposium

Multiple IFH researchers presented research findings at NJ ACTS’s Community Engaged Scholarship Symposium in June.

Tobias Gerhard Elected New Member of American Epidemiological Society

IFH’s Interim Director, Tobias Gerhard, was elected new member of AES – an honorary society with a mission to provide a scientific forum for senior epidemiologists.

iPHD logo
New Jersey Health Data Project Tackles State’s Pressing Health Needs

Rutgers Center for State Health Policy launched the New Jersey Integrated Population Health Data (iPHD) Project to address some of the state’s most pressing health care issues

Diverted Buprenorphine May Help Prepare People With Opioid-Use Disorder for Treatment

IFH’s Stephen Crystal coauthors study on how use of buprenorphine prior to entering opioid disorder treatment can prepare patients to stay in care.

1 2 10 11